The researchers found that when a pharmacist was stationed in the ED, the coagulation drug was delivered faster, which reduced the time the patient was in the intensive care unit and resulted in shorter hospital stays.
In fact, when a pharmacist was present in the ED, patients received the coagulation drug in a median time of 66.5 minutes, while those without a pharmacist received the coagulation drug in a median time of 206.5 minutes, according to News Medical. The authors said that the time reduction was a result of the pharmacist being able to communicate with the central pharmacy in a more timely manner.
Patients with a pharmacist spent an average of two days in the ICU and 5.5 days in the hospital. Patients without a pharmacist spent an average of five days in intensive care and eight days in the hospital, the study found.
Read the full report here.
More articles on pharmacy:
FDA approves AbbVie’s $59K rheumatoid arthritis drug
Teva launches generic version of EpiPen for kids
American Regent boosted price of essential hospital product by 1,300%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
